Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma

被引：0

作者：

I Sekine

H Nokihara

A Horiike

N Yamamoto

H Kunitoh

Y Ohe

T Tamura

T Kodama

N Saijo

机构：

[1] National Cancer Center Hospital,Divisions of Internal Medicine and Thoracic Oncology

[2] Tsukiji 5-1-1,undefined

[3] Chuo-ku,undefined

来源：

British Journal of Cancer | 2004年 / 90卷

关键词：

squamous cell carcinoma; paclitaxel; nedaplatin; lung cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The recommended phase II dose of paclitaxel 180 mg m−2 given as a 3-h infusion followed by nedaplatin 100 mg m−2 in a 1-h infusion every 3–4 weeks was determined in 52 chemo-naive patients with unresectable squamous cell carcinoma (SCC), with a promising response rate for lung SCC of 55%.

引用

页码：1125 / 1128

页数：3

共 50 条

[1] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
Sekine, I
Nokihara, H
Horiike, A
Yamamoto, N
Kunitoh, H
Ohe, Y
Tamura, T
Kodama, T
Saijo, N
BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1125 - 1128
[2] Phase II study of nedaplatin, a cisplatin analogue, and docetaxel in patients with advanced squamous cell lung carcinoma
Naito, Yoichi
Kubota, Kaoru
Ohmatsu, Hironobu
Goto, Koichi
Niho, Seiji
Yoh, Kiyotaka
Saijo, Nagahiro
Nishiwaki, Yutaka
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S452 - S452
[3] Phase i study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer
Sekine, Ikuo
Sumi, Minako
Ito, Yoshinori
Kato, Terufumi
Fujisaka, Yasuhito
Nokihara, Hiroshi
Yamamoto, Noboru
Kunitoh, Hideo
Ohe, Yuichiro
Tamura, Tomohide
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (03) : 175 - 180
[4] Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma
Hanauske, AR
Schilling, T
Heinrich, B
Kau, R
Herzog, M
Quasthoff, S
Bochtler, H
Diergarten, K
Rastetter, J
SEMINARS IN ONCOLOGY, 1995, 22 (06) : 35 - 39
[5] Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study
Yu, N.
Li, J.
Chen, X.
Wang, Z.
Kang, X.
Zhang, R.
Qin, J.
Zheng, Q.
Feng, G.
Deng, L.
Zhang, T.
Wang, W.
Liu, W., Jr.
Wang, J.
Feng, Q.
Lv, J.
Chen, D.
Zhou, Z.
Xiao, Z.
Li, Y.
Bi, N.
Li, Y.
Wang, X.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E354 - E354
[6] Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix
Kodama, J.
Takemoto, M.
Seki, N.
Nakamura, K.
Hongo, A.
Moriya, S.
Kanazawa, S.
Hiramatsu, Y.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (06) : 1300 - 1304
[7] A phase Ⅱ study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma
Yi-Fu He
Chu-Shu Ji
Bing Hu
Ping-Sheng Fan
Chang-Lu Hu
Feng-Shou Jiang
Jian Chen
Lei Zhu
Yi-Wei Yao
Wei Wang
World Journal of Gastroenterology, 2013, (35) : 5910 - 5916
[8] Phase I Study of Nedaplatin Prior to S-1 in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
Sato, Dai
Kogashiwa, Yasunao
Tsukahara, Kiyoaki
Yamauchi, Koichi
Kohno, Naoyuki
CHEMOTHERAPY, 2013, 59 (04) : 314 - 318
[9] In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers
Monk, BJ
Alberts, DS
Burger, RA
Fanta, PT
Hallum, AV
Hatch, KD
Salmon, SE
GYNECOLOGIC ONCOLOGY, 1998, 71 (02) : 308 - 312
[10] In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers
David S. Alberts
Paul T. Fanta
Kelli L. Running
Laurence P. Adair Jr.
Dava J. Garcia
Rosa Liu-Stevens
Sydney E. Salmon
Cancer Chemotherapy and Pharmacology, 1997, 39 : 493 - 497

← 1 2 3 4 5 →